Increased Expression of High-Mobility Group Protein B1 in Chronic Rhinosinusitis
Abstract
Background
Chronic rhinosinusitis (CRS) is an inflammation of the sinonasal mucosa and many inflammatory cells and cytokines are involved in its pathogenesis. High-mobility group protein B1 (HMGB1) is a DNA-binding protein that has a proinflammatory function when secreted into extracellular space. The purpose of this study was to evaluate the expression of HMGB1 in paranasal sinus mucosa and to determine the difference of HMGB1 expression between CRS patients and normal controls.
Methods
Paranasal sinus mucosa was obtained from 10 patients with CRS and 10 patients without CRS. Semiquantitative reverse transcriptase–polymerase chain reaction (RT-PCR), real-time PCR and Western blot analysis were performed to detect mRNA and protein. Sections of the mucosa were immunostained for localization of HMGB1 and image analysis was performed.
Results
RT-PCR and real-time PCR showed that the expression level of HMGB1 mRNA was significantly increased in the tissues of patients with CRS compared with controls. Western blot analysis showed that the expression level of HMGB1 protein was significantly increased in the tissues of CRS. In immunohistochemical staining, the HMGB1 protein was expressed in epithelial cells and inflammatory cells and the expression intensity of HMGB1 protein was stronger in CRS.
Conclusion
HMGB1 is increased in the paranasal sinus mucosa of patients with CRS. These results suggest a possible contribution of HMGB1 in the pathophysiology of CRS.
Get full access to this article
View all access and purchase options for this article.
References
1. Wood A.J. and Douglas R.G. Pathogenesis and treatment of chronic rhinosinusitis. Postgrad Med J 86: 359–364, 2010.
2. Demoly P. Crampette L. Mondain M.et al. Assessment of inflammation in noninfectious chronic maxillary sinusitis. J Allergy Clin Immunol 94: 95–108, 1994.
3. Bachert C. Wagenmann M. Rudack C.et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 53: 2–13, 1998.
4. Sanchez-Segura A. Brieva J.A. and Rodriguez C. T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol 102: 953–960, 1998.
5. Hsu J. and Peters A.T. Pathophysiology of chronic rhinosinusitis with nasal polyp. Am J Rhinol Allergy 25: 285–290, 2011.
6. Hori O. Brett J. Slattery T.et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270: 25752–25761, 1995.
7. Muller S. Scaffidi P. Degryse B.et al. New EMBO members’ review: The double life of HMGB1 chromatin protein: Architectural factor and extracellular signal. EMBO J 20: 4337–4340, 2001.
8. Scaffidi P. Misteli T. and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191–195, 2002.
9. Lotze M.T. and Tracey K.J. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331–342, 2005.
10. Karlsson S. Pettila V. Tenhunen J.et al. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care Med 34: 1046–1053, 2008.
11. Rowe S.M. Jackson P.L. Liu G.et al. Potential role of high-mobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med 178: 822–831, 2008.
12. Taniguchi N. Kawahara K. Yone K.et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48: 971–981, 2003.
13. Newman L.J. Platts-Mills T.A. Phillips C.D.et al. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA 271: 363–367, 1994.
14. Ferhani N. Letuve S. Kozhich A.et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181: 917–927, 2010.
15. Ito Y. Bhawal U.K. Sasahira T.et al. Involvement of HMGB1 and RAGE in IL-1beta-induced gingival inflammation. Arch Oral Biol 57: 73–80, 2012.
16. Hou C. Zhao H. Liu L.et al. High mobility group protein B1 (HMGB1) in asthma: Comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 17: 807–815, 2011.
17. Liu S. Stolz D.B. Sappington P.L.et al. HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am J Physiol Cell Physiol 290: C990–C999, 2006.
18. Hamada N. Maeyama T. Kawaguchi T.et al. The role of high mobility group box1 in pulmonary fibrosis. Am J Respir Cell Mol Biol 39: 440–447, 2008.
19. Thomas J.O. HMG1 and 2: Architectural DNA-binding proteins. Biochem Soc Trans 29: 395–401, 2001.
20. Sims G.P. Rowe D.C. Rietdijk S.T.et al. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28: 367–388, 2010.
21. Wang H. Bloom O. Zhang M.et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248–251, 1999.
22. Rendon-Mitchell B. Ochani M. Li J.et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 170: 3890–3897, 2003.
23. Kim J.H. Kim S.J. Lee I.S.et al. Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway. J Immunol 182: 2458–2466, 2009.
24. Messmer D. Yang H. Telusma G.et al. High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 173: 307–313, 2004.
25. Orlova V.V. Choi E.Y. Xie C.et al. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 26: 1129–1139, 2007.
26. Fiuza C. Bustin M. Talwar S.et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101: 2652–2660, 2003.
27. Kokkola R. Li J. Sundberg E.et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 48: 2052–2058, 2003.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: April 27, 2018
Issue published: July/August 2013
PubMed: 23883808
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in American Journal of Rhinology & Allergy.
VIEW ALL JOURNAL METRICSArticle usage*
Total views and downloads: 31
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 0
Crossref: 16
- High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associat...
- Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Disea...
- Ethyl pyruvate ameliorate inflammatory response of sinonasal mucosa by...
- High Mobility Group Box Chromosomal Protein-1 Induces Myofibroblast Di...
- Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
- HMGB1 in nasal inflammatory diseases: a reappraisal 30 years after its...
- Cysteinyl leukotriene receptor 2 drives lung immunopathology through a...
- Baicalin Down-Regulates IL-1β-Stimulated Extracellular Matrix Producti...
- HMGB1-TLR4 Signaling Contributes to the Secretion of Interleukin 6 and...
- Impact of Histone H1 on the Progression of Allergic Rhinitis and Its S...
- Rhinosinusal Inflammation and High Mobility Group Box 1 Protein: A New...
- Ethyl pyruvate attenuates murine allergic rhinitis partly by decreasin...
- Level of secreted HMGB1 correlates with severity of inflammation in ch...
- Physiologic Concentrations of HMGB1 Have No Impact on Cytokine-Mediate...
- HMGB1 in health and disease
- Osteitis is Associated with P-Glycoprotein Overexpression in Patients ...
Figures and tables
Figures & Media
Tables
View Options
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
